【ChiCTR2400094247】Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
ChiCTR2400094247
尚未开始
/
/
/
2024-12-19
/
/
chronic pain
Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
121000
The study aims to develop and examine the effectiveness of the online gamified pain management (GPM) for chronic pain among adults in mainland China. To this end, the objectives will be: 1) examine the effects of the GPM intervention on the levels of pain intensity, pain interference, psychological outcomes and quality of life among adults in mainland China. 2) identify the relationships between the effects of the intervention and socio-demographic factors. 3) explore the perceptions, attitudes and experiences after participating in the intervention.
随机平行对照
探索性研究/预试验
Eligible participants will be randomly assigned to either the GPM intervention (experimental group) or the online handout intervention (control group) using an online randomizer (True Random Number Service) with a 1:1 ratio by a blinded student member who is not involved in study design, assessment or the intervention delivery.
All participants will be blinded to their group allocation until the intervention delivered.
None
/
110
/
2024-12-31
2025-06-30
/
1) Aged older than 18 years old 2) Able to read and understand the Mandarin Chinese language 3) Owners of smartphones with internet access 4) Have a previously diagnosed chronic non-cancer pain condition lasting more than three months (Treede et al., 2019) 5) Report a score of ≥2 on the VAS scale；
请登录查看1) Patients with associated pathologies that make it impossible to perform physical exercise (myopathies, neurological diseases, cardiac disease, pregnancy, pulmonary diseases, infection and fracture) 2) Individuals undergoing surgery or invasive treatments in the last three months 3) Concurrent participation (or participation within the preceding 3 months) in a supervised exercise programme or multidisciplinary treatment；
请登录查看Hong Kong Metropolitan University
999077
Hong Kong Metropolitan University的其他临床试验
- Effectiveness of an immersive virtual reality (VR)-based mindfulness intervention (MI) to reduce depressive symptoms in patients with autoimmune arthritis (AA): a randomized control trial (RCT)
- Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
- Acute and chronic musculoskeletal pain situations among adults and their educational requirements on pain in mainland China: an exploratory study
- The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risks older adults in Hong Kong: a pilot study
School of Nursing and Health, Hong Kong Metropolitan University的其他临床试验
- Effectiveness of an immersive virtual reality (VR)-based mindfulness intervention (MI) to reduce depressive symptoms in patients with autoimmune arthritis (AA): a randomized control trial (RCT)
- Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04